Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Budget Impact Analysis of Eliglustat for the Treatment of Gaucher Disease Type 1 in the United States.

Nalysnyk L, Sugarman R, Cele C, Uyei J, Ward A.

J Manag Care Spec Pharm. 2018 Oct;24(10):1002-1008. doi: 10.18553/jmcp.2018.24.10.1002.

2.

A health state utility valuation study to assess the impact of treatment mode of administration in Gaucher disease.

Hadi M, Swinburn P, Nalysnyk L, Hamed A, Mehta A.

Orphanet J Rare Dis. 2018 Sep 10;13(1):159. doi: 10.1186/s13023-018-0903-6. Review.

3.

A new framework for evaluating the health impacts of treatment for Gaucher disease type 1.

Ganz ML, Stern S, Ward A, Nalysnyk L, Selzer M, Hamed A, Weinreb N.

Orphanet J Rare Dis. 2017 Feb 20;12(1):38. doi: 10.1186/s13023-017-0592-6.

4.

Gaucher disease epidemiology and natural history: a comprehensive review of the literature.

Nalysnyk L, Rotella P, Simeone JC, Hamed A, Weinreb N.

Hematology. 2017 Mar;22(2):65-73. doi: 10.1080/10245332.2016.1240391. Epub 2016 Oct 20. Review.

PMID:
27762169
5.

A Comprehensive Literature Review of the Burden of Gaucher Disease.

Nalysnyk L, Hamed A, Hurwitz G, Simeone J, Rotella P.

Value Health. 2014 Nov;17(7):A391. doi: 10.1016/j.jval.2014.08.858. Epub 2014 Oct 26. No abstract available.

6.

Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature.

Kistler KD, Nalysnyk L, Rotella P, Esser D.

BMC Pulm Med. 2014 Aug 16;14:139. doi: 10.1186/1471-2466-14-139. Review.

7.

OnabotulinumtoxinA muscle injection patterns in adult spasticity: a systematic literature review.

Nalysnyk L, Papapetropoulos S, Rotella P, Simeone JC, Alter KE, Esquenazi A.

BMC Neurol. 2013 Sep 8;13:118. doi: 10.1186/1471-2377-13-118. Review.

8.

Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature.

Nalysnyk L, Cid-Ruzafa J, Rotella P, Esser D.

Eur Respir Rev. 2012 Dec 1;21(126):355-61. doi: 10.1183/09059180.00002512. Review.

9.

Mortality and morbidity among infants at high risk for severe respiratory syncytial virus infection receiving prophylaxis with palivizumab: a systematic literature review and meta-analysis.

Checchia PA, Nalysnyk L, Fernandes AW, Mahadevia PJ, Xu Y, Fahrbach K, Welliver RC Sr.

Pediatr Crit Care Med. 2011 Sep;12(5):580-8. doi: 10.1097/PCC.0b013e3182070990. Review.

PMID:
21200358
10.

Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature.

Nalysnyk L, Hernandez-Medina M, Krishnarajah G.

Diabetes Obes Metab. 2010 Apr;12(4):288-98. doi: 10.1111/j.1463-1326.2009.01160.x. Review.

PMID:
20380649
11.

Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: a descriptive study of a large outpatient oncology practice database, 2000-2007.

Wu Y, Aravind S, Ranganathan G, Martin A, Nalysnyk L.

Clin Ther. 2009;31 Pt 2:2416-32. doi: 10.1016/j.clinthera.2009.11.020.

PMID:
20110050
12.

Ultrasonic and nonultrasonic instrumentation: a systematic review and meta-analysis.

Matthews B, Nalysnyk L, Estok R, Fahrbach K, Banel D, Linz H, Landman J.

Arch Surg. 2008 Jun;143(6):592-600. doi: 10.1001/archsurg.143.6.592. Review.

PMID:
18559754
13.

Intermediate and long-term outcomes of total ankle arthroplasty and ankle arthrodesis. A systematic review of the literature.

Haddad SL, Coetzee JC, Estok R, Fahrbach K, Banel D, Nalysnyk L.

J Bone Joint Surg Am. 2007 Sep;89(9):1899-905. Review.

PMID:
17768184
14.

Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis.

Reynolds MW, Fahrbach K, Hauch O, Wygant G, Estok R, Cella C, Nalysnyk L.

Chest. 2004 Dec;126(6):1938-45. Review.

PMID:
15596696
15.

Adverse events in coronary artery bypass graft (CABG) trials: a systematic review and analysis.

Nalysnyk L, Fahrbach K, Reynolds MW, Zhao SZ, Ross S.

Heart. 2003 Jul;89(7):767-72. Review.

16.

Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review.

Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, Komaroff E, Nalysnyk L, Zilberberg MD.

Radiother Oncol. 2003 Mar;66(3):253-62. Review.

PMID:
12742264
17.

Discontinuation of antihypertensive drugs due to adverse events: a systematic review and meta-analysis.

Ross SD, Akhras KS, Zhang S, Rozinsky M, Nalysnyk L.

Pharmacotherapy. 2001 Aug;21(8):940-53.

PMID:
11718500

Supplemental Content

Loading ...
Support Center